Praxis Precision Medicine (NASDAQ:PRAX) reported quarterly losses of $(2.75) per share which missed the analyst consensus estimate of $(1.99) by 38.19 percent. The company reported quarterly sales of $302.000 thousand which beat the analyst consensus estimate of $296.000 thousand by 2.03 percent. This is a 35.47 percent decrease over sales of $468.000 thousand the same period last year.